B. al Wakeel - 25 Jul 2022 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Chief Financial Officer
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
25 Jul 2022
Net transactions value
$0
Form type
4
Filing time
27 Jul 2022, 18:22:44 UTC
Previous filing
08 Jul 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Award $0 +53,600 +33% $0.000000 216,841 25 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Employee Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 25 Jul 2022 Common Stock 40,000 $5.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares subject to the stock option shall vest and become exercisable on June 30, 2023 and the remaining shares shall vest and become exercisable on December 31, 2023.